Crohn’s Disease

The STARSCAPE Study Program is a series of Phase 3 clinical trials for people with moderately to severely active Crohn’s disease (CD). The program includes an induction study (STARSCAPE-1) and a maintenance study (STARSCAPE-2) evaluating the effectiveness and safety of the investigational study drug.1

Get Your Patient FormDownload Brochure
804-250-9859
Get Your Patient Form
Summary
Participants will attend regular study visits for checkups, symptom tracking, questionnaires, and sample collections. Some assessments (e.g. colonoscopies, blood work) help monitor the course of disease and response to treatment. The investigational study drug may be self-administered at home.
Age
Are 18 years or older. In some countries, participation may be possible from age 16.
Qualifications
  • Have been diagnosed with moderate to severe Crohn’s disease at least 3 months ago that is currently active.
  • Have frequent diarrhea and/or abdominal pain.
  • Have not responded well to previous CD treatments or could not tolerate them.
  • Are willing to follow all study procedures, including clinic visits, colonoscopies, and symptom tracking.

Meet Our Team

Our experienced team will guide you through the process

Meet the Team

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Mimi Franzen Canada

Chief Operations Officer

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Lisa Smith, BSN, RN

Director of Quality Assurance

Joy Walker

Director of Business Development

Aundraya Bray, LCSW

Clinical Operations Coordinator

Shawn Mease, CCRC, NRP, CCEMT-P

Director of Study Start-Up